| CYHS2101144 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-12 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| CYHS2101145 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(4) | Generic Drug | 2021-05-12 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| JTH2100638 | 奥希替尼薄膜衣片 | osimertinib mesylate | Tablet | Chemical Drugs | Disposable Import Drug Application | 2021-09-03 | | AstraZeneca AB;Hutchison MediPharma Co Ltd;Astrazeneca Uk Ltd | | | view |
| JTH2300035 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Disposable Import Drug Application | 2023-02-11 | | AstraZeneca AB;Hutchison MediPharma Co Ltd | | | view |
| JTH2500009 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Disposable Import Drug Application | 2025-02-09 | | AstraZeneca AB;Hutchison MediPharma Co Ltd | | | view |
| JXHB2200039 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-03-24 | | AstraZeneca AB | | | view |
| JXHB2200040 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-03-24 | | AstraZeneca AB | | | view |
| JXHL1600100 | 奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2016-08-31 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-01-20 | view |
| JXHL1600101 | 奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2016-08-31 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-01-20 | view |
| JXHL1800075 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-07-09 | | AstraZeneca AB | Certificate Issued | 2018-09-04 | view |
| JXHL1800076 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-07-09 | | AstraZeneca AB | Certificate Issued | 2018-09-04 | view |
| JXHL1900320 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-22 | | AstraZeneca AB | In Review | 2019-11-21 | view |
| JXHL1900321 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2019-11-22 | | AstraZeneca AB | In Review | 2019-11-21 | view |
| JXHL2000305 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2020-11-18 | view |
| JXHL2000306 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2020-11-18 | view |
| JXHL2100067 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-03-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2021-03-02 | view |
| JXHL2100068 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-03-03 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd;AstraZeneca AB | In Review | 2021-03-02 | view |
| JXHL2101015 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-04-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHL2101016 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-04-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXHL2101218 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2021-10-28 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
